Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipoprotein metabolism refers to the complex processes by which lipoproteins—biochemical assemblies of lipids and proteins—transport hydrophobic lipid molecules (such as cholesterol and triglycerides) through the aqueous environment of plasma. This system is essential for distributing dietary and endogenously synthesized fats throughout the body, supporting cellular energy needs, membrane synthesis, and hormone production.
Varies depending on the specific drug; includes inhibition of cholesterol synthesis (statins), activation of PPARα (fibrates), inhibition of cholesterol absorption (ezetimibe), inhibition of PCSK9 (PCSK9 inhibitors), reduction of VLDL secretion (Niacin)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipoprotein Metabolism.